From January 1, 2024 to March 11, 2024, the company has repurchased 5,607,225 shares, representing 4.21% for CNY 172.59 million. With this, the company has completed the repurchase of 6,412,625 shares, representing 4.81% for CNY 199.59 million under the buyback announced on June 6, 2023.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
Equities
301093
CNE100004YH2
Tires & Rubber Products
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.1 CNY | +1.05% | -9.44% | -34.67% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.67% | 37Cr | |
+13.08% | 2.92TCr | |
+21.79% | 648.09Cr | |
+14.17% | 381.7Cr | |
+65.09% | 380.16Cr | |
-3.48% | 360.18Cr | |
-16.03% | 347.32Cr | |
+10.97% | 287.75Cr | |
+16.02% | 270.08Cr | |
+8.50% | 267.8Cr |
- Stock Market
- Equities
- 301093 Stock
- News Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
- Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.